Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular underpinnings beyond genetic predisposition. Epigenetic modifications, ...

The research presented in the article delves into the regulatory role of the long non-coding RNA (lncRNA) ZNF593-AS in cardiac hypertrophy and myocardial remodeling, processes that are pivotal in the ...

Future Cardiol. 2013;9(5):697-709. Geometry Asymmetric hypertrophy out of proportion to hypertension Concentric remodeling or hypertrophy Symmetric LV hypertrophy that is proportional to exercise ...

Relatives with a pathogenic sarcomere gene variant have a lower risk for serious cardiac events than patients with hypertrophic cardiomyopathy but a higher risk than relatives without the variant.

Myocardial hypertrophy is a condition characterized by thickening of the ventricular wall and commonly associated with progression to heart failure. It develops when the heart is subjected to ...

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular condition. It is the leading cause of sudden cardiac death in young people and children, with an annual mortality rate of 1% ...

Treating patients with HCM is guided by how severe symptoms are, whether a patient has any risk factors for sudden cardiac death, and whether a patient has cardiac arrhythmias and other associated ...

The findings show exercise-induced hypertension increases myocardial oxygen demand. A new review suggests exercise-induced hypertension (EIH) is a risk factor for sudden cardiac death (SCD), but that ...

Hypertrophic cardiomyopathy (HCM) is the leading cause of sudden cardiac death (SCD) in young athletes, according to the ...

The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...